Measurement of biological age may help to assess the risk of colorectal adenoma in screening colonoscopy

Table 3 Clinical characteristics between biological age-dominant and chronological age-dominant groups

	BA-dominant group (n = 28)	CA-dominant group (n = 76)	P value
Age (yr, mean ± SD)	42.00 (35.25-49.75)	52.00 (43.25-59.00)	0.001
Gender			0.013
Male	25 (89.3)	49 (64.5)
Female	3 (10.3)	27 (35.5)
High blood pressure			< 0.001
Yes (%)	11 (39.3)	6 (7.9)
No (%)	17 (60.7)	70 (92.1)
Fasting glucose (mg/dL)	88.00 (82.00-97.50)	81.00 (75.25-87.00)	< 0.001
HbA1c	5.55 (5.30-5.80)	5.30 (5.20-5.50)	0.001
CEA	1.91 (0.97-3.20)	1.67 (1.03-2.57)	0.858
Metabolic syndrome			< 0.001
Yes	7 (25.0)	1 (1.3)
No	21 (75.0)	75 (98.7)

High blood pressure systolic blood pressure/diastolic blood pressure > 140/90 mmHg. Data expressed as median (P₂₅-P₇₅), or absolute number (%). BA: Biological age; CA: Chronological age; HbA1c: Hemoglobin A1c; CEA: Carcinoembryonic antigen.